← Leaderboards
John Gerard Flannery
University Of California Berkeley
$5,301,136
Attributed
$8,205,031
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$8,205,031 · 4
By mechanism
R01$8,205,031 · 4
Top collaborators
- Joseph C Corbo5 shared
- David V Schaffer5 shared
- Ehud Isacoff4 shared
Most similar at University Of California Berkeley
Same institution · by research overlap
- David V Schaffer$16,640,690
- Lin Tian$15,975,679
- Evan Walker Miller$7,557,158
- Ehud Isacoff$55,644,117
- Dirk Trauner$7,161,668
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyRetinitis PigmentosaRetinal DegenerationEngineeringRetinaBlindnessBaseVisionPhotoreceptorsRetinalPhotophobiaAdeno-Associated Viral VectorGene TransferOptogeneticsPhotoreceptor DegenerationRestorationLightDesignConeMutationCellsInterneuronsInherited Retinal DegenerationCell Death
Grant awards (20)
Optogenetic Vision Restoration$380,725
R01 · FY2021 · EY · contact PI
Optogenetic Vision Restoration$392,500
R01 · FY2020 · EY · contact PI
CONVERTING BIPOLAR CELLS INTO RED-SHIFTED OPTOGENETIC SENSORS FOR RETINAL THERAPY$419,657
R01 · FY2019 · EY
Optogenetic Vision Restoration$392,500
R01 · FY2019 · EY · contact PI
CONVERTING BIPOLAR CELLS INTO RED-SHIFTED OPTOGENETIC SENSORS FOR RETINAL THERAPY$419,657
R01 · FY2018 · EY
Optogenetic Vision Restoration$392,500
R01 · FY2018 · EY · contact PI
Directed Evolution of Adeno-Associated Virus for Retinal Gene Therapy$337,048
R01 · FY2018 · EY
CONVERTING BIPOLAR CELLS INTO RED-SHIFTED OPTOGENETIC SENSORS FOR RETINAL THERAPY$442,532
R01 · FY2017 · EY
Directed Evolution of Adeno-Associated Virus for Retinal Gene Therapy$408,538
R01 · FY2017 · EY
CONVERTING BIPOLAR CELLS INTO RED-SHIFTED OPTOGENETIC SENSORS FOR RETINAL THERAPY$442,532
R01 · FY2016 · EY
Directed Evolution of Adeno-Associated Virus for Retinal Gene Therapy$410,681
R01 · FY2016 · EY
CONVERTING BIPOLAR CELLS INTO RED-SHIFTED OPTOGENETIC SENSORS FOR RETINAL THERAPY$471,872
R01 · FY2015 · EY
Directed Evolution of Adeno-Associated Virus for Retinal Gene Therapy$411,418
R01 · FY2015 · EY
Directed Evolution of Adeno-Associated Virus for Retinal Gene Therapy$485,631
R01 · FY2014 · EY
Viral Mediated Gene Therapy for Retinal Diseases$369,471
R01 · FY2005 · EY
Viral Mediated Gene Therapy for Retinal Diseases$366,699
R01 · FY2004 · EY
Viral Mediated Gene Therapy for Retinal Diseases$517,191
R01 · FY2003 · EY
Viral Mediated Gene Therapy for Retinal Diseases$425,727
R01 · FY2002 · EY
Viral Mediated Gene Therapy for Retinal Diseases$361,911
R01 · FY2002 · EY
Viral Mediated Gene Therapy for Retinal Diseases$356,241
R01 · FY2001 · EY